Biochemical evidence of functional interaction between μ- and δ-opioid receptors in SK-N-BE neuroblastoma cell line

Journal of Neurochemistry

Volumn 67, Issue 1, 1996, Pages 138-144

  Palazzi, Elisabetta ^a   Ceppi, Elena ^a   Guglielmetti, Filippo ^a   Catozzi, Lidia ^a   Amoroso, Daniela ^a   Groppetti, Antonio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adenylyl cyclase activity; Functional interaction; Neuroblastoma cell lines; and opioid receptors

Indexed keywords

ADENYLATE CYCLASE; DELTA OPIATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; CANCER CELL CULTURE; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; LIGAND BINDING; NERVE CELL CULTURE; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

EID: 0029888644     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67010138.x     Document Type: Article

References (37)

1. Attali B., Saya D., and Vogel Z. (1989) κ-Opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord. J. Neurochem. 52, 360-369.
2. Biedler J. L. and Spengler B. A. (1976) Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science 191, 185-187.
3. Biedler J. L., Roffler-Tarlov S., Schachner M., and Freedman L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757.
4. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Chen Y., Mestek A., Liu J., Hurley J. A., and Yu L. (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
6. Collier H. O. J. and Roy A. C. (1974) Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenates. Nature 248, 24-27.
7. Corbett A. D., Paterson S. J., and Kosterlitz H. W. (1993) Selectivity of ligands for opioid receptors, in Handbook of Experimental Pharmacology, Vol. 104: Opioids, Part II (Herz A., Akil H., and Simon E. J., eds), pp. 645-679. Springer-Verlag, Berlin.
8. Cruciani R. A., Dvorkin B., Morris S. A., Crain S. M., and Makman M. H. (1993) Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc. Natl. Acad. Sci. USA 90, 3019-3023.
9. Evans C. J., Keith D. E. Jr., Morrison H., Magendzo K., and Edwards R. H. (1992) Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
10. Frey A. and Kebabian J. W. (1984) μ-Opiate receptors in 7315c tumor tissue mediate inhibition of immunoreactive prolactin release and adenylate cyclase activity. Endocrinology 115, 1797-1804.
11. Jiang Q., Mosberg H. I., and Porreca F. (1990) Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther. 254, 683-689.
12. Kazmi S. M. I. and Mishra R. K. (1987) Comparative pharmacological properties and functional coupling of μ and δ opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 32, 109-118.
13. Kieffer B. L., Befort K., Gaveriaux-Ruff C., and Hirth C. G. (1992) The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89, 12048-12052.
14. Klee W. A. and Nirenberg M. (1974) A neuroblastoma × glioma hybrid cell line with morphine receptors. Proc. Natl. Acad. Sci. USA 71, 3174-3177.
15. Kosky G. and Klee W. A. (1981) Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proc. Natl. Acad. Sci. USA 78, 4185-4189.
16. 2OH is a selective ligand for the μ-opiate binding site. Br. J. Pharmacol. 73, 299P.
17. Lee N. M., Leybin L., Chang J. K., and Loh H. H. (1980) Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur. J. Pharmacol. 68, 181-185.
18. Lord J. A. H., Waterfield A. A., Hughes J., and Kosterlitz H. W. (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267, 495-499.
19. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., and Gilbert P. E. (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517-532.
20. Munson P. J. and Rodbard D. (1980) LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
21. Nishi M., Takeshima H., Fukuda K., Kato S., and Mori K. (1993) cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for κ-subtype-selective ligands. FEBS Lett. 330, 77-80.
22. North R. A. (1986) Opioid receptor types and membrane ion channels. Trends Pharmacol. Sci. 9, 114-117.
23. Olianas M. C. and Onali P. (1992) Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb. Mol. Pharmacol. 42, 109-115.
24. Paterson S. J., Robson L. E., and Kosterlitz H. W. (1983) Classification of opioid receptors. Br. Med. Bull. 39, 31-36.
25. Pert C. B. and Snyder S. H. (1973) Opiate receptor: demonstration in nervous tissue. Science 179, 1011-1014.
26. Polastron J. and Jauzac P. (1994) Different subtypes of opioid receptors have different affinities for G-proteins. Cell. Mol. Biol. (Noisy le grand) 40, 389-401.
27. Polastron J., Boyer M.-J., Quertermont Y., Thouvenot J.-P., Meunier J.-C., and Jauzac P. (1990) μ-Opioid receptors and non κ-opioid receptors are coupled to the adenylate cyclase in the cerebellum. J. Neurochem. 54, 562-570.
28. Polastron J., Mur M., Marzaguil H., Puget A., Meunier J.-C., and Jauzac P. (1994) SK-N-BE: a human neuroblastoma cell line containing two subtypes of δ-opioid receptors. J. Neurochem. 62, 898-906.
29. 125I]β-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/ delta opioid receptor complex. J. Pharmacol. Exp. Ther. 253, 419-426.
30. 3H]etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. USA 70, 1947-1949.
31. Smith C. F. C. (1987) 16-Me cyprenorphine (RX 8008M): a potent opioid antagonist with some δ selectivity. Life Sci. 40, 267-274.
32. Terenius L. (1973) Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol. Toxicol. 33, 377-384.
33. Traynor J. R. and Elliott J. (1993) δ-Opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol. Sci. 14, 84-85.
34. Tsunoo A., Yoshii M., and Narahashi T. (1986) Block of calcium channels by enkephalin and somatostatin in neuroblastoma × glioma hybrid cells. Proc. Natl. Acad. Sci. USA 83, 9832-9836.
35. Vaught J. L. and Takemori A. E. (1979) Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther. 208, 86-90.
36. White A. A. and Karr D. B. (1978) Improved two-step method for the assay of adenylate and guanylate cyclase. Anal. Biochem. 85, 451-460.
37. Yu V. C., Richards M. L., and Sadee W. (1986) A human neuroblastoma cell line expresses μ and δ opioid receptor sites. J. Biol. Chem. 261, 1065-1070.